India Launches First Biosimilar for World's Top-selling Drug

India-based Cadila Healthcare has launched the first biosimilar version of the world's top-selling drug anti-inflammatory medicine adalimumab.

France's Pierre Fabre to Cut 550 Jobs; Focus on U.S., Asia

The french drugmaker has announced it will cut 551 R&D and sales jobs by 2016, almost exclusively in France, in order to focus on expanding its dermatology and cosmetics division.

Study Finds Opioid-Painkiller Cocktails Can Be Deadly

In 2013, nearly 60 percent of people using opiate pain medications were taking them with another drug in a potentially hazardous combination

OtisMed Pays $80M for Distributing FDA-rejected Cutting Guides

OtisMed and former CEO plead guilty for distributing FDA-rejected cutting guides for knee replacement surgeries

Patent Losses Put a Costly Damper on Merck's Cubist Buy

Regulators Suspend Drug Approvals for 25 Generics Tied to Faulty Bio-equivalence Studies

Regulators in France, Germany, Belgium and Luxembourg are suspending the marketing approval of 25 generic drugs due to concerns over data quality from clinical trials conducted by India's GVK Biosciences.

Hovione Files Milestone IND for Topical Zit Zapper

Minocycline gel is a novel formulation to administer topically using a new patented crystalline base form of minocycline

Pfizer Bets on Gene Therapy with Spark Therapeutics Deal

Spark gene therapy biotech will partner with established market leader Pfizer to develop a potential new treatment paradigm for hemophilia B.

Merck to Buy Cubist Pharma for $8.4B

Cubist focuses on antibiotics to treat serious and life-threatening infections caused by a broad range of increasingly drug-resistant bacteria

EU Bans Imports of Ranbaxy Injectables

The European Union has banned imports from the Ranbaxy Laboratories' Dewas plant, which manufactures injectable antibotics, after the unit failed an inspection.

Wall Street-Savvy Cybercriminals Target Pharma: Have You Been Hacked?

A new report from FireEye says that a cybercriminal group has been stealing data from more than 100 organizations, mainly targeting publicly traded health care, pharmaceutical and biotechnology companies, to gain insider knowledge to manipulate the stock market.

Sanofi Kickback Allegations: No Comment

A former employee has filed a lawsuit in the U.S. against Sanofi, alleging that the French drugmaker paid $34 million in kickbacks for doctors, pharmacies and hospitals to order its diabetes treatments.

India Hosts National Seminar on QbD for Pharmaceutical Research

PAT & Quality by Design Conference

Otsuka to Acquire Avanir for $3.5 Billion

The company seeks to expand its neurologic drug portfolio before expiration of a key drug patent

GSK to Announce Restructuring, Hundreds of Layoffs

GlaxoSmithKline said it will cut costs by $1.57 billion over three years

FDA Approves Non-invasive Device to Analyze Heart Blood Flow

FDA allowed marketing of HeartFlow FFR-CT software for patients showing signs and symptoms of coronary artery disease

Protein Sciences to Submit Ebola Vaccine by End of the Year

The next step will be animal testing of the vaccine on monkeys, which will the be exposed to the Ebola virus

FDA Approves Hydrocodone Product for Treating Severe Pain

FDA approves Hysingla ER, an extended-release opioid analgesic with abuse-deterrent properties to treat pain severe enough to require around-the-clock, long-term opioid treatment

U.S. Court Overturns Ranbaxy's Bid to Block Rival Generics

A U.S. court has denied a request by India's Ranbaxy Laboratories to stop competitors from launching generic copies of AstraZeneca's heartburn pill Nexium and Roche's antiviral, Valcyte.